ALS Canada Offers Vital Support Through Equipment Loan Program
Living with amyotrophic lateral sclerosis (ALS) presents profound challenges—not only medically but financially. To ease this burden, ALS Canada operates a critical equipment loan program that provides essential mobility and care devices to individuals and families navigating the disease. Among the items available is a new travel buggy: an electric, lightweight wheelchair weighing just 22 pounds, designed to be easily stored in a car for greater independence and accessibility.
The Unpredictable Nature of ALS
ALS manifests differently in each person and can progress rapidly, making it difficult for patients and caregivers to anticipate care needs. “We hope that people with ALS don’t fall through the cracks of the health care system,” says Kim Barry, vice-president of community services at ALS Canada. “One day someone is relatively stable, and by the end of that week they’ve already changed. So they need a lot more support.”
Sudden shifts in condition often require immediate access to professional home care, occupational therapist evaluations, specialized equipment, and training for family members. In more advanced cases, when care needs exceed what can be safely managed at home, placement in a long-term care facility may become necessary.
Funding Challenges Behind the Scenes
The equipment loan program costs approximately $1.8 million annually to operate and relies on a combination of donations, fundraising efforts, and government support. In 2024, the provincial government contributed $3.2 million—an increase from previous years—but this funding is renewable, meaning ALS Canada must continually demonstrate the program’s impact and necessity.
“We have core funding for community services, but our equipment program is funded through renewable resources,” Barry explains. “We still have to show it delivers real value.” She highlights how even basic items like walkers—costing around $500—may only be needed for a few months due to the disease’s rapid progression, making loan programs a practical and compassionate solution.
A Growing Need in a Rare but Devastating Disease
Approximately 4,000 Canadians currently live with ALS, with 1,000 new diagnoses each year. While classified as a rare disease, ALS is not as uncommon as many assume. Its severity is underscored by a stark reality: 80% of those diagnosed will pass away within two to five years.
Though no cure exists, certain medications can slow progression in some patients. Notably, a newer drug targeting the genetic form of ALS has shown promise in halting disease advancement and improving symptoms in a small subset of cases.
Through its responsive, knowledgeable support network and equipment loan initiative, ALS Canada continues to stand alongside patients and caregivers during one of life’s most difficult journeys.
